Volume 60, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
Volume 63, Issue 1, Pages (July 2015)
Volume 53, Issue 1, Pages (July 2010)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 56, Issue 4, Pages (April 2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 59, Issue 6, Pages (December 2013)
Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials  Pippa Newell, Augusto Villanueva, Josep M. Llovet 
Volume 68, Issue 5, Pages (May 2018)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Non-invasive diagnosis of non-alcoholic fatty liver disease
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Mesenchymal stromal cell therapy for liver diseases
The place of downstaging for hepatocellular carcinoma
Autoimmune hepatitis: A life-long disease
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 66, Issue 2, Pages (February 2017)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
The heart in liver transplantation
Economics of chronic hepatitis B and hepatitis C
The changing role of beta-blocker therapy in patients with cirrhosis
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 57, Issue 5, Pages (November 2012)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 66, Issue 3, Pages (March 2017)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
A 360-degree overview of paediatric NAFLD: Recent insights
Volume 54, Issue 6, Pages (June 2011)
Volume 55, Pages S3-S16 (June 1999)
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Friedrich Foerster, Peter Robert Galle  JHEP Reports 
Presentation transcript:

Volume 60, Issue 6, Pages 1268-1289 (June 2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma  John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik, Gregory J. Gores  Journal of Hepatology  Volume 60, Issue 6, Pages 1268-1289 (June 2014) DOI: 10.1016/j.jhep.2014.01.021 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Incidence of cholangiocarcinoma worldwide where reported. Journal of Hepatology 2014 60, 1268-1289DOI: (10.1016/j.jhep.2014.01.021) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Signaling pathways and molecular therapies in intrahepatic cholangiocarcinoma. Adapted by permission from McMillan Publishers Ltd.: Oncogene [59], Copyright (2013). Journal of Hepatology 2014 60, 1268-1289DOI: (10.1016/j.jhep.2014.01.021) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 A suggested treatment algorithm for patients with iCCA.∗ These are standard of practice recommendations. Larger and appropriate studies are required to provide evidence for standard of care guidelines. Journal of Hepatology 2014 60, 1268-1289DOI: (10.1016/j.jhep.2014.01.021) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1268-1289DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions